Ligand Pharmaceuticals
LGND
#4083
Rank
S$3.05 B
Marketcap
$161.76
Share price
-2.21%
Change (1 day)
115.59%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.08

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.10. In 2022 the company made an earnings per share (EPS) of -$2.65 a decrease over its 2021 EPS that were of $4.64.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.08-178.31%
2022-$2.65-157.23%
2021$4.64-2571.43%
2020-$0.19-100.46%
2019$41.01353.48%
2018$9.041025%
2017$0.80-700%
2016-$0.13-100.87%
2015$15.491859.32%
2014$0.795.36%
2013$0.758.0704505322479E+18%
2012$0.0000000000-100%
2011$0.66-194.23%
2010-$0.70548.38%
2009-$0.11-98.7%
2008-$8.28-136.52%
2007$22.67-787.8%
2006-$3.30-14.58%
2005-$3.86-21.31%
2004-$4.90-55.15%
2003-$10.9381.33%
2002-$6.032.74%
2001-$5.87-45.93%
2000-$10.85-14.56%
1999-$12.70-45.52%
1998-$23.31-3.97%
1997-$24.28132.31%
1996-$10.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.96 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.69 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.44 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.49 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.27 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.32 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.86 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.87 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA